ArticleJAMA network open2026
Prehospital Point-of-Care GFAP for Detection of Intracranial Hemorrhage in Acute Nontraumatic Coma.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Rapid identification of intracranial hemorrhage (ICH) in patients with acute nontraumatic coma is critical to guiding triage and early management; however, prehospital diagnostic tools remain limited. Objective: To evaluate the diagnostic accuracy of prehospital whole-blood point-of-care measurement of glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) for detecting ICH. Design, Setting, and Participants: This diagnostic study used data collected by a UK physician-paramedic helicopter emergency medical service between January 1, 2025, and April 30, 2026. A consecutive sample of adult patients (aged ≥16 years) presenting with acute nontraumatic coma, defined as Glasgow Coma Scale (GCS) score of 12 or less, who underwent prehospital rapid sequence induction (RSI) of anesthesia with clinical suspicion of ICH were eligible for inclusion. Patients with traumatic pathology and those without follow-up data were excluded. Patients were observed for up for 30 days from hospital admission. Data analysis was performed in June 2026. Exposure: Prehospital whole-blood point-of-care brain biomarker (GFAP and UCH-L1) testing using the i-STAT Alinity Point-of-Care Blood Analyzer (Abbott Laboratories). Main Outcome and Measures: Diagnostic accuracy of GFAP and UCH-L1 for detecting ICH, using computed tomography as the reference standard. Sensitivity, specificity, predictive value, and area under the receiver operating characteristic curve (AUC) were calculated. Results: The primary study cohort comprised 65 patients who underwent prehospital brain biomarker testing (median age, 63 [IQR, 47-69] years; 55.4% male). The median (IQR) GCS score was 4 (3-6). ICH was present in 50.8% (n = 33). Thirteen (20.0%) patients underwent neurosurgery, and the 30-day survival rate was 46.2% (n = 30). GFAP demonstrated high sensitivity (97.0%; 95% CI, 84.2%-99.9%) and discriminatory ability (AUC, 0.94; 95% CI, 0.87-0.99). UCH-L1 showed lower sensitivity (78.8%; 95% CI, 61.1%-91.0%) and specificity (18.8%; 95% CI, 7.2%-36.4%), with limited discriminatory performance. A combined biomarker approach achieved 100.0% sensitivity (95% CI, 89.4%-100.0%) and a negative predictive value of 100.0% (95% CI, 47.8%-100.0%). Conclusions and Relevance: In this diagnostic study of adults with acute nontraumatic coma undergoing prehospital RSI, point-of-care prehospital GFAP testing was feasible and demonstrated high diagnostic accuracy in detecting intracranial hemorrhage. Further prospective external validation is required to determine its association with triage, treatment decisions, and patient outcomes.
Indexed as
Identifiers
42879151What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.